Search research articles
Contact Us
Filters
Showing results (71-80 of 117) with videos related to
Page
of 12
Sort By:
European Journal of Haematology
|
April 15, 2026
First-Line Treatment of IGHV-Unmutated Chronic Lymphocytic Leukemia: A Network Meta-Analysis of Targeted and Chemoimmunotherapy Regimens
Santino Caserta, Enrica Antonia Martino, Danilo Lofaro, et al.
British Journal of Haematology
|
March 29, 2026
Exploiting ALK inhibition in anaplastic large cell lymphoma: Biological rationale and therapeutic integration
Santino Caserta, Enrica Antonia Martino, Mamdouh Skafi, et al.
European Journal of Haematology
|
April 20, 2026
From Time-Limited Therapy to Treatment-Free Observation: The Evolving Role of MRD in CLL Management
Enrica Antonia Martino, Santino Caserta, Ernesto Vigna, et al.
Annals of Hematology
|
May 4, 2026
High-dose ruxolitinib (25 mg twice daily) in myelofibrosis: feasibility, safety, and long-term treatment exposure in a real-world cohort
Francesco Mendicino, Giulio Caridà, Antonella Bruzzese, et al.
European Journal of Haematology
|
July 9, 2026
Bridging Randomized Trial Efficacy and Real-World Effectiveness in Multiple Myeloma: Integrating Clinical Trials and Real-World Evidence for Individualized Care
Enrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, et al.
Leukemia & Lymphoma
|
August 23, 2008
The incidence of JAK2 V617F mutation in bcr/abl-negative chronic myeloproliferative disorders: assessment by two different detection methods
Eugenio Lucia, Bruno Martino, Corrado Mammi, et al.
European Journal of Haematology
|
February 19, 2025
Relapsed/Refractory Follicular Lymphoma: Current Advances and Emerging Perspectives
Giulio Caridà, Enrica Antonia Martino, Antonella Bruzzese, et al.
Drug Design, Development and Therapy
|
July 15, 2021
Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma
Fortunato Morabito, Giovanni Tripepi, Enrica Antonia Martino, et al.
European Journal of Haematology
|
April 27, 2026
Minimal Residual Disease as a Biological Trait: Rethinking Disease Persistence in Hematologic Malignancies
Santino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
British Journal of Haematology
|
July 22, 2014
Italian external and multicentric validation of the MD Anderson Cancer Center nomogram and prognostic index for chronic lymphocytic leukaemia patients: analysis of 1502 cases
Massimo Gentile, Francesca R Mauro, Davide Rossi, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 117) with videos related to
Sort By:
Page
of 12
European Journal of Haematology
|
April 15, 2026
First-Line Treatment of IGHV-Unmutated Chronic Lymphocytic Leukemia: A Network Meta-Analysis of Targeted and Chemoimmunotherapy Regimens
Santino Caserta, Enrica Antonia Martino, Danilo Lofaro, et al.
British Journal of Haematology
|
March 29, 2026
Exploiting ALK inhibition in anaplastic large cell lymphoma: Biological rationale and therapeutic integration
Santino Caserta, Enrica Antonia Martino, Mamdouh Skafi, et al.
European Journal of Haematology
|
April 20, 2026
From Time-Limited Therapy to Treatment-Free Observation: The Evolving Role of MRD in CLL Management
Enrica Antonia Martino, Santino Caserta, Ernesto Vigna, et al.
Annals of Hematology
|
May 4, 2026
High-dose ruxolitinib (25 mg twice daily) in myelofibrosis: feasibility, safety, and long-term treatment exposure in a real-world cohort
Francesco Mendicino, Giulio Caridà, Antonella Bruzzese, et al.
European Journal of Haematology
|
July 9, 2026
Bridging Randomized Trial Efficacy and Real-World Effectiveness in Multiple Myeloma: Integrating Clinical Trials and Real-World Evidence for Individualized Care
Enrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, et al.
Leukemia & Lymphoma
|
August 23, 2008
The incidence of JAK2 V617F mutation in bcr/abl-negative chronic myeloproliferative disorders: assessment by two different detection methods
Eugenio Lucia, Bruno Martino, Corrado Mammi, et al.
European Journal of Haematology
|
February 19, 2025
Relapsed/Refractory Follicular Lymphoma: Current Advances and Emerging Perspectives
Giulio Caridà, Enrica Antonia Martino, Antonella Bruzzese, et al.
Drug Design, Development and Therapy
|
July 15, 2021
Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma
Fortunato Morabito, Giovanni Tripepi, Enrica Antonia Martino, et al.
European Journal of Haematology
|
April 27, 2026
Minimal Residual Disease as a Biological Trait: Rethinking Disease Persistence in Hematologic Malignancies
Santino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
British Journal of Haematology
|
July 22, 2014
Italian external and multicentric validation of the MD Anderson Cancer Center nomogram and prognostic index for chronic lymphocytic leukaemia patients: analysis of 1502 cases
Massimo Gentile, Francesca R Mauro, Davide Rossi, et al.
Page
of 12